title: N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment.
authors.forename: Theodoros
authors.initials: T
authors.lastname: Dimitroulas
authors.forename: Georgios
authors.initials: G
authors.lastname: Giannakoulas
authors.forename: Haralambos
authors.initials: H
authors.lastname: Karvounis
authors.forename: Hara
authors.initials: H
authors.lastname: Dimitroula
authors.forename: Loukas
authors.initials: L
authors.lastname: Settas
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood* / Q000188:drug therapy* / Q000209:etiology; D008954:Models, Biological; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D012595:Scleroderma, Systemic / Q000097:blood / Q000150:complications; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D010446:Peptide Fragments; D013449:Sulfonamides; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D000077300:Bosentan